Market closed
enVVeno Medical/$NVNO
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About enVVeno Medical
enVVeno Medical Corp is a medical device company focused on the development of bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. Its product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).
Ticker
$NVNO
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
31
Website
enVVeno Medical Metrics
BasicAdvanced
$44M
Market cap
-
P/E ratio
-$1.33
EPS
1.22
Beta
-
Dividend rate
Price and volume
Market cap
$44M
Beta
1.22
52-week high
$6.97
52-week low
$2.45
Average daily volume
151K
Financial strength
Current ratio
22.006
Quick ratio
21.704
Long term debt to equity
1.67
Total debt to equity
2.423
Management effectiveness
Return on assets (TTM)
-37.28%
Return on equity (TTM)
-58.76%
Valuation
Price to book
0.92
Price to tangible book (TTM)
0.92
Price to free cash flow (TTM)
-2.368
Growth
Earnings per share change (TTM)
-47.47%
3-year earnings per share growth (CAGR)
-11.90%
What the Analysts think about enVVeno Medical
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for enVVeno Medical stock.
enVVeno Medical Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
enVVeno Medical Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
enVVeno Medical News
AllArticlesVideos
enVVeno Medical Successfully Completes Final Wave of Implants in Pre-Clinical GLP Study for enVVe
Accesswire·5 days ago
enVVeno Medical Highlights Successful 2024 VEITH Symposium with Launch of Recap Website
Accesswire·3 weeks ago
enVVeno Medical to Present Definitive One Year Data from the VenoValve U.S. Pivotal Trial Today at the 51st Annual VEITH Symposium
Accesswire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for enVVeno Medical stock?
enVVeno Medical (NVNO) has a market cap of $44M as of December 21, 2024.
What is the P/E ratio for enVVeno Medical stock?
The price to earnings (P/E) ratio for enVVeno Medical (NVNO) stock is 0 as of December 21, 2024.
Does enVVeno Medical stock pay dividends?
No, enVVeno Medical (NVNO) stock does not pay dividends to its shareholders as of December 21, 2024.
When is the next enVVeno Medical dividend payment date?
enVVeno Medical (NVNO) stock does not pay dividends to its shareholders.
What is the beta indicator for enVVeno Medical?
enVVeno Medical (NVNO) has a beta rating of 1.22. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.